Pluri (PLUR) Change in Account Payables (2010 - 2025)
Pluri (PLUR) posted quarterly Change in Account Payables of $122000.0 for Q4 2025, up 771.43% year-over-year from $14000.0 in Q4 2024, and up 20.79% quarter-over-quarter from $101000.0 in Q3 2025.
Pluri (PLUR) Change in Account Payables (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Change in Account Payables for 16 consecutive years, with $122000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Account Payables rose 771.43% year-over-year to $122000.0; the TTM figure through Dec 2025 stood at -$176000.0 (down 277.78% YoY), while the FY2025 annual figure was -$235000.0, up 69.79% from the prior year.
- Change in Account Payables climbed to $122000.0 in Q4 2025 per PLUR's latest filing, from $101000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $432000.0 in Q2 2021 and bottomed at -$883000.0 in Q3 2023.
- Historically, Change in Account Payables has averaged -$90850.0 across 5 years, with a median of -$10000.0 in 2024.
- On a YoY basis, Change in Account Payables climbed as much as 771.43% in 2025 and fell as far as 1306.9% in 2025.
- Pluri's Change in Account Payables stood at $291000.0 in 2021, then tumbled by 123.02% to -$67000.0 in 2022, then surged by 353.73% to $170000.0 in 2023, then slumped by 91.76% to $14000.0 in 2024, then soared by 771.43% to $122000.0 in 2025.
- Business Quant data shows PLUR's Change in Account Payables at $122000.0 in Q4 2025, $101000.0 in Q3 2025, and $9000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 122,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 122,000.00 |
| Dec 31, 2025 | 122,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Sep 30, 2025 | 101,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Jun 30, 2025 | 9,000.00 |
| Mar 31, 2025 | -408,000.00 |
| Mar 31, 2025 | -408,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | -36,000.00 |
| Jun 30, 2024 | -36,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Sep 30, 2023 | -883,000.00 |
| Sep 30, 2023 | -883,000.00 |